表紙:ラテラルフローアッセイの世界市場の予測 (2027年まで) :製品別、用途別、技術別、エンドユーザー別
市場調査レポート
商品コード
1023345

ラテラルフローアッセイの世界市場の予測 (2027年まで) :製品別、用途別、技術別、エンドユーザー別

Global Lateral Flow Assays Market by Product (Kits & Reagents, Instruments), Application (Clinical Testing, Veterinary, Food Safety), Technique (Sandwich, Multiplex), End User (Hospital, Diagnostic Labs) - Global Forecast to 2027

出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 285 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
ラテラルフローアッセイの世界市場の予測 (2027年まで) :製品別、用途別、技術別、エンドユーザー別
出版日: 2021年08月17日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 285 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のラテラルフローアッセイ市場は、2027年までに140億米ドルに達し、2020年からのCAGRで9%の成長が予測されています。この成長の主な要因は、感染症の蔓延、高齢者人口の増加、POC検査や家庭用ラテラルフローアッセイデバイスの需要の増加です。

当レポートでは、世界のラテラルフローアッセイ市場について調査分析し、市場概要、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • ラテラルフローアッセイ市場に対するCOVID-19の影響

第5章 業界考察

  • イントロダクション
  • 業界動向

第6章 世界のラテラルフローアッセイ市場:製品別

  • キット・試薬
  • ラテラルフローリーダー

第7章 世界のラテラルフローアッセイ市場:技術別

  • サンドイッチ法
  • 競合法
  • マルチプレックス検出法

第8章 世界のラテラルフローアッセイ市場:サンプル別

  • 血液サンプル
  • 尿サンプル
  • 唾液サンプル
  • その他のサンプル

第9章 世界のラテラルフローアッセイ市場:用途別

  • 臨床試験
  • 獣医用診断
  • 食品安全・環境試験
  • 医薬品開発・品質試験

第10章 世界のラテラルフローアッセイ市場:エンドユーザー別

  • 病院・クリニック
  • 診断研究所
  • 在宅医療
  • 製薬・バイオテクノロジー企業
  • その他のエンドユーザー

第11章 世界のラテラルフローアッセイ市場:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第12章 競合情勢

  • イントロダクション
  • 市場シェア分析:主要企業別
  • 競合状況と動向

第13章 企業プロファイル

  • Abbott Laboratories (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Siemens AG (Germany)
  • Becton, Dickinson and Company (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories (US)
  • Thermo Fisher Scientific, Inc. (US)
  • PerkinElmer Inc. (US)
  • Hologic Inc. (US)
  • Quidel Corporation (US)
  • Merck KGaA (Germany)
  • Abcam plc (UK)
  • Surmodics IVD (US)
  • Chembio Diagnostic Systems, Inc. (US)
  • OraSure Technologies (US)
  • DCN Diagnostics (US)
  • Polysciences, Inc. (US)
  • Abingdon Health (UK)
  • BioPorto Diagnostics A/S (Denmark)
  • Microcoat Biotechnologie GmbH (Germany)
  • Scienion AG (Germany)
  • Senova GmbH (Germany)
  • Access Bio, Inc. (US)

第14章 付録

目次
Product Code: MEDE2106

The global lateral flow assays market is expected to grow at a CAGR of ~9% from 2020 to reach ~14 billion by 2027. The growth is primarily attributed to prevalence of infectious diseases, growing geriatric population, increasing demand for POC testing and home-based lateral flow assay devices. However, lower accuracy and high margin of error associated with lateral flow assays is expected to hinder the growth of the market.

By Product: The lateral flow readers segment to grow at highest CAGR

The lateral flow readers provide the quantitative analysis of lateral flow strips. The lateral flow readers are expected to grow at the highest CAGR during the forecast period. The growth can be mainly attributed to high sensitivity and ability to quantify and accurately capture and transmit data.

By Technique: Sandwich assays accounted for the largest market share in 2020

Sandwich assays segment accounted for the largest market share of the lateral flow assay market, by technique in 2020. The large market share is mainly attributed to higher sensitivity, specificity for larger analyte and wide use of these assays.

By Sample Type: Other samples segment expected to register highest growth

Based on sample type, other samples segment is expected to grow at the highest CAGR in the forecast period. The growth is mainly ascribed by increasing R&D investments and escalating demand for precise disease testing.

By Application: Clinical testing expected to hold largest share in the lateral flow assays market

By application, lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environment testing and drug development & quality testing. Clinical testing accounted for largest market share in the lateral flow assays market by application in 2020. This segment is further classified into pregnancy & fertility testing, infectious disease testing, cardiac marker testing, cholesterol testing/lipid profiles, drugs-of-abuse testing and other tests. The large share of this segment can be attributed to faster results for qualitative and quantitative analysis in POC testing.

By End User: Hospitals & clinics to dominate the lateral flow assays market

Hospitals & clinics segment accounted for largest share of the lateral flow segment market, by end user in 2020. The large share is mainly attributed to growing adoption of lateral flow assays, advantages over conventional testing and increased demand due to pandemic.

By Region: North America expected to dominate the regional market

North America is expected to dominate the lateral flow assays market by region. The large share is primarily attributed to prevalence of infectious diseases such as tuberculosis, Lyme disease, HIV/AIDS, increasing disposable income and rising geriatric population in the North America region. The pandemic has further boosted the market by increased investments in R&D. APAC is expected to register highest CAGR. The growth can be attributed to prevalence of chronic diseases, government initiatives and increasing healthcare expenditure in these countries.

Competitive Scenario

  • Abbott Laboratories (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Siemens AG (Germany)
  • Becton, Dickinson and Company (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories (US)
  • Thermo Fisher Scientific, Inc. (US)
  • PerkinElmer Inc. (US)
  • Hologic Inc. (US)
  • Quidel Corporation (US)
  • Merck KGaA (Germany)
  • Abcam plc (UK)
  • Surmodics IVD (US)
  • Chembio Diagnostic Systems, Inc. (US)
  • OraSure Technologies (US)
  • DCN Diagnostics (US)
  • Polysciences, Inc. (US)
  • Abingdon Health (UK)
  • BioPorto Diagnostics A/S (Denmark)
  • Microcoat Biotechnologie GmbH (Germany)
  • Scienion AG (Germany)
  • Senova GmbH (Germany)
  • and Access Bio, Inc. (US)

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Lateral Flow Assay Market

5. Industry Insights

  • 5.1. Introduction
  • 5.2. Industry Trends

6. Global Lateral Flow Assay Market, By Product, 2019-2027 (USD Million)

  • 6.1. Kits & reagents
  • 6.2. Lateral flow readers

7. Global Lateral Flow Assay Market, By Technique, 2019-2027 (USD Million)

  • 7.1. Sandwich Assays
  • 7.2. Competitive Assays
  • 7.3. Multiplex Detection Assays

8. Global Lateral Flow Assay Market, By Sample, 2019-2027 (USD Million)

  • 8.1. Blood Samples
  • 8.2. Urine Samples
  • 8.3. Saliva Samples
  • 8.4. Other Samples

9. Global Lateral Flow Assay Market, By Application, 2019-2027 (USD Million)

  • 9.1. Clinical Testing
  • 9.2. Veterinary Diagnostics
  • 9.3. Food safety & Environment Testing
  • 9.4. Drug Development & Quality Testing

10. Global Lateral Flow Assay Market, By End User, 2019-2027 (USD Million)

  • 10.1. Hospitals & Clinics
  • 10.2. Diagnostics Laboratories
  • 10.3. Home Care Settings
  • 10.4. Pharmaceutical & Biotechnology Companies
  • 10.5. Other End Users

11. Global Lateral Flow Assay Market, By Geography, 2019-2027 (USD Million)

  • 11.1. North America
    • 11.1.1. US
    • 11.1.2. Canada
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. UK
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of the World
    • 11.4.1. Latin America
    • 11.4.2. Middle East & Africa

12. Competitive Landscape

  • 12.1. Introduction
  • 12.2. Market Share Analysis, By Key Players (2020)
  • 12.3. Competitive Situation and Trends
    • 12.3.1. Product Launches
    • 12.3.2. Partnerships, Collaborations and Agreements
    • 12.3.3. Acquisitions
    • 12.3.4. Expansions
    • 12.3.5. Other Developments

13. Company Profiles

  • 13.1. Abbott Laboratories (US)
  • 13.2. F. Hoffman-La Roche Ltd. (Switzerland)
  • 13.3. Danaher Corporation (US)
  • 13.4. Siemens AG (Germany)
  • 13.5. Becton, Dickinson and Company (US)
  • 13.6. bioMerieux SA (France)
  • 13.7. Bio-Rad Laboratories (US)
  • 13.8. Thermo Fisher Scientific, Inc. (US)
  • 13.9. PerkinElmer Inc. (US)
  • 13.10. Hologic Inc. (US)
  • 13.11. Quidel Corporation (US)
  • 13.12. Merck KGaA (Germany)
  • 13.13. Abcam plc (UK)
  • 13.14. Surmodics IVD (US)
  • 13.15. Chembio Diagnostic Systems, Inc. (US)
  • 13.16. OraSure Technologies (US)
  • 13.17. DCN Diagnostics (US)
  • 13.18. Polysciences, Inc. (US)
  • 13.19. Abingdon Health (UK)
  • 13.20. BioPorto Diagnostics A/S (Denmark)
  • 13.21. Microcoat Biotechnologie GmbH (Germany)
  • 13.22. Scienion AG (Germany)
  • 13.23. Senova GmbH (Germany)
  • 13.24. Access Bio, Inc. (US)

14. Appendix